ArticleHealth science reports2026
HIV Burden Trends in Kyrgyzstan, 1990-2025: A National Analysis of GBD 2021 Estimates and Short-Term Projections.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kyrgyzstan has experienced sustained HIV transmission, yet comprehensive national assessments of long-term trends and demographic inequalities remain limited. This study evaluated the national HIV burden and benchmarked Kyrgyzstan's progress against Middle-SDI and global patterns. Methods: We obtained HIV prevalence, mortality, and disability-adjusted life years (DALYs) for 1990-2021 from the Global Burden of Disease Study 2021. Age-standardized prevalence (ASPR), death (ASDR), and DALY rates per 100,000 population were examined by age and sex. Estimated annual percentage changes (EAPCs) with 95% confidence intervals were calculated using log-linear regression. Values for 2022-2025 were short-term projections derived by extrapolating 2010-2021 trends and were not official GBD estimates. We obtained transmission-mode information from national surveillance sources and analyzed it descriptively. Results: HIV prevalence increased throughout 1990-2021 and was projected to reach an ASPR of 22.8 per 100,000 in 2025. Mortality and DALY rates peaked around 2010 and subsequently declined, although improvements were slower than global benchmarks. Adults aged 20-49 years experienced the greatest burden, while males generally had higher mortality and DALY rates than females. Surveillance data indicated an increasing proportion of diagnoses attributed to heterosexual exposure; however, recent evidence suggests possible underreporting of injecting-drug-use and male-to-male sexual exposure. Conclusions: Kyrgyzstan has achieved partial reductions in fatal HIV burden, but increasing prevalence indicates continuing transmission and long-term treatment needs. Expanded testing, sustained antiretroviral therapy, harm reduction, and differentiated services for key populations and their sexual partners remain essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.